EP Patent

EP1418924A2 — Single dose azithromycin for treating respiratory infections

Assigned to Pfizer Products Inc · Expires 2004-05-19 · 22y expired

What this patent protects

The present invention relates to a method of treating respiratory infections in humans by administering a single dose of azithromycin.

USPTO Abstract

The present invention relates to a method of treating respiratory infections in humans by administering a single dose of azithromycin.

Drugs covered by this patent

amikacin-sulfate (AMIKACIN SULFATE)

Patent Metadata

Patent number: EP1418924A2
Jurisdiction: EP
Classification: —
Expires: 2004-05-19
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Products Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.